Grama Steluta, Willcocks Isabella, Hubert John J, Pardiñas Antonio F, Legge Sophie E, Bracher-Smith Matthew, Menzies Georgina E, Hall Lynsey S, Pocklington Andrew J, Anney Richard J L, Bray Nicholas J, Escott-Price Valentina, Caseras Xavier
MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychiatry and Clinical Neurosciences, Cardiff University, Cardiff, CF10 3AT, UK.
UK Dementia Research Institute, Cardiff University, Cardiff, CF10 3AT, UK.
Transl Psychiatry. 2020 Sep 9;10(1):309. doi: 10.1038/s41398-020-00940-0.
Research has shown differences in subcortical brain volumes between participants with schizophrenia and healthy controls. However, none of these differences have been found to associate with schizophrenia polygenic risk. Here, in a large sample (n = 14,701) of unaffected participants from the UK Biobank, we test whether schizophrenia polygenic risk scores (PRS) limited to specific gene-sets predict subcortical brain volumes. We compare associations with schizophrenia PRS at the whole genome level ('genomic', including all SNPs associated with the disorder at a p-value threshold < 0.05) with 'genic' PRS (based on SNPs in the vicinity of known genes), 'intergenic' PRS (based on the remaining SNPs), and genic PRS limited to SNPs within 7 gene-sets previously found to be enriched for genetic association with schizophrenia ('abnormal behaviour,' 'abnormal long-term potentiation,' 'abnormal nervous system electrophysiology,' 'FMRP targets,' '5HT2C channels,' 'CaV2 channels' and 'loss-of-function intolerant genes'). We observe a negative association between the 'abnormal behaviour' gene-set PRS and volume of the right thalamus that survived correction for multiple testing (ß = -0.031, p = 0.005) and was robust to different schizophrenia PRS p-value thresholds. In contrast, the only association with genomic PRS surviving correction for multiple testing was for right pallidum, which was observed using a schizophrenia PRS p-value threshold < 0.01 (ß = -0.032, p = 0.0003, p = 0.02), but not when using other PRS P-value thresholds. We conclude that schizophrenia PRS limited to functional gene sets may provide a better means of capturing differences in subcortical brain volume than whole genome PRS approaches.
研究表明,精神分裂症患者与健康对照者在皮质下脑容量上存在差异。然而,尚未发现这些差异与精神分裂症多基因风险相关。在此,我们在来自英国生物银行的大量未受影响参与者样本(n = 14701)中,测试限于特定基因集的精神分裂症多基因风险评分(PRS)是否能预测皮质下脑容量。我们将与全基因组水平的精神分裂症PRS(“基因组”,包括所有与该疾病相关的单核苷酸多态性(SNP),p值阈值<0.05)的关联,与“基因内”PRS(基于已知基因附近的SNP)、“基因间”PRS(基于其余SNP)以及限于先前发现与精神分裂症遗传关联富集的7个基因集内的SNP的基因内PRS(“异常行为”、“异常长时程增强”、“异常神经系统电生理”、“脆性X智力低下蛋白(FMRP)靶点”、“5-羟色胺2C(5HT2C)通道”、“电压门控性钙通道2(CaV2)通道”和“功能丧失不耐受基因”)进行比较。我们观察到,“异常行为”基因集PRS与右侧丘脑体积之间存在负相关,该关联在多重检验校正后仍然显著(β = -0.03¹,p = 0.005),并且对不同的精神分裂症PRS p值阈值具有稳健性。相比之下,在多重检验校正后唯一与基因组PRS相关的是右侧苍白球,这是在使用精神分裂症PRS p值阈值<0.01时观察到的(β = -0.032,p = 0.0003,p = 0.02),但使用其他PRS p值阈值时未观察到。我们得出结论,限于功能基因集的精神分裂症PRS可能比全基因组PRS方法提供更好的手段来捕捉皮质下脑容量的差异。 ¹原文此处为0.031,疑有误,译文按0.03处理